ReP USP - Resultado da busca

Artigo de periodico
MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil (2022)
Castelli, Erick C ; Castro, Mateus Vidigal de ; Naslavsky, Michel ; Scliar, Marilia O ; Silva, Nayane S. B; Pereira, Raphaela Neto ; Ciriaco, Viviane A. O; Castro, Camila F. B; Mendes Junior, Celso Teixeira ; Silveira, Etiele de S ; Oliveira, Iuri M. de; Antonio, Eduardo C; Vieira, Gustavo F ; Meyer, Diogo ; Nunes, Kelly ; Matos, Larissa R. B; Bortolin, Raul Hernandes ; Hirata, Mario Hiroyuki
Unidades: IB, FFCLRP, FCF
Subjects: COVID-19, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTELLI, Erick C et al. MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil. v. 13, p. 1-15 art. 975918, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.975918. Acesso em: 02 nov. 2024.
APA
Castelli, E. C., Castro, M. V. de, Naslavsky, M., Scliar, M. O., Silva, N. S. B., Pereira, R. N., et al. (2022). MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil, 13, 1-15 art. 975918. doi:10.3389/fimmu.2022.975918
NLM
Castelli EC, Castro MV de, Naslavsky M, Scliar MO, Silva NSB, Pereira RN, Ciriaco VAO, Castro CFB, Mendes Junior CT, Silveira E de S, Oliveira IM de, Antonio EC, Vieira GF, Meyer D, Nunes K, Matos LRB, Bortolin RH, Hirata MH. MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil [Internet]. 2022 ; 13 1-15 art. 975918.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2022.975918
Vancouver
Castelli EC, Castro MV de, Naslavsky M, Scliar MO, Silva NSB, Pereira RN, Ciriaco VAO, Castro CFB, Mendes Junior CT, Silveira E de S, Oliveira IM de, Antonio EC, Vieira GF, Meyer D, Nunes K, Matos LRB, Bortolin RH, Hirata MH. MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil [Internet]. 2022 ; 13 1-15 art. 975918.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2022.975918
Artigo de periodico
Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states (2022)
Schimke, Lena Friederike ; Marques, Alexandre Henrique Carvalho ; Baiocchi, Gabriela Crispim ; Prado, Caroline Aliane de Souza ; Fonseca, Dennyson Leandro Mathias da; Freire, Paula Paccielli ; Plaça, Desirée Rodrigues ; Filgueiras, Igor Salerno ; Salgado, Ranieri Coelho ; Marques, Gabriel Jansen; Oliveira, Antonio Edson Rocha ; Peron, Jean Pierre Schatzmann ; Miranda, Gustavo Cabral; Barbuto, José Alexandre Marzagão ; Câmara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Ochs, Hans D.; Condino Neto, Antonio ; Nakaya, Helder Takashi Imoto ; Overmyer, Katherine A.; Coon, Joshua J.
Source: Cells. Unidades: ICB, BIOTECNOLOGIA, FCF, EACH
Subjects: IMUNOLOGIA, COVID-19, EXPRESSÃO GÊNICA, TRANSCRIÇÃO GÊNICA, NEUTRÓFILOS, COVID-19, INFLAMAÇÃO, CITOCINAS, QUIMIOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHIMKE, Lena Friederike et al. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells, v. 11, n. 5, p. 1-24, 2022Tradução . . Disponível em: https://doi.org/10.3390/cells11050847. Acesso em: 02 nov. 2024.
APA
Schimke, L. F., Marques, A. H. C., Baiocchi, G. C., Prado, C. A. de S., Fonseca, D. L. M. da, Freire, P. P., et al. (2022). Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells, 11( 5), 1-24. doi:10.3390/cells11050847
NLM
Schimke LF, Marques AHC, Baiocchi GC, Prado CA de S, Fonseca DLM da, Freire PP, Plaça DR, Filgueiras IS, Salgado RC, Marques GJ, Oliveira AER, Peron JPS, Miranda GC, Barbuto JAM, Câmara NOS, Calich VLG, Ochs HD, Condino Neto A, Nakaya HTI, Overmyer KA, Coon JJ. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states [Internet]. Cells. 2022 ; 11( 5): 1-24.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/cells11050847
Vancouver
Schimke LF, Marques AHC, Baiocchi GC, Prado CA de S, Fonseca DLM da, Freire PP, Plaça DR, Filgueiras IS, Salgado RC, Marques GJ, Oliveira AER, Peron JPS, Miranda GC, Barbuto JAM, Câmara NOS, Calich VLG, Ochs HD, Condino Neto A, Nakaya HTI, Overmyer KA, Coon JJ. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states [Internet]. Cells. 2022 ; 11( 5): 1-24.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/cells11050847
Artigo de periodico
MHC variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals (2021)
Castelli, Erick C ; Castro, Mateus V. de ; Naslavsky, Michel ; Scliar, Marília Oliveira ; Silva, Nayane S. B; Andrade, Heloisa S; Souza, Andréia S; Pereira, Raphaela Neto; Castro, Camila Ferreira Bannwart ; Mendes Júnior, Celso Teixeira ; Meyer, Diogo ; Nunes, Kelly ; Matos, Larissa R. B; Silva, Moníze Valéia Ramos da ; Wang, Jaqueline Yu Ting; Esposito, Joyce ; Cória, Vivian Romanholi ; Bortolin, Raul Hernandes ; Hirata, Mario Hiroyuki ; Magawa, Jhosiene Yukari; Cunha Neto, Edecio ; Coelho, Veronica P ; Santos, Keity Souza ; Marin, Maria Lucia C ; Kalil Filho, Jorge Elias ; Mitne Neto, Miguel ; Maciel, Rui Monteiro de Barros ; Passos-Bueno, Maria Rita ; Zatz, Mayana
Source: Frontiers in Immunology. Unidades: IB, FFCLRP, FCF, FM
Subjects: COVID-19, SISTEMA IMUNE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTELLI, Erick C et al. MHC variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals. Frontiers in Immunology, v. 12, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.742881. Acesso em: 02 nov. 2024.
APA
Castelli, E. C., Castro, M. V. de, Naslavsky, M., Scliar, M. O., Silva, N. S. B., Andrade, H. S., et al. (2021). MHC variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals. Frontiers in Immunology, 12, 1-11. doi:10.3389/fimmu.2021.742881
NLM
Castelli EC, Castro MV de, Naslavsky M, Scliar MO, Silva NSB, Andrade HS, Souza AS, Pereira RN, Castro CFB, Mendes Júnior CT, Meyer D, Nunes K, Matos LRB, Silva MVR da, Wang JYT, Esposito J, Cória VR, Bortolin RH, Hirata MH, Magawa JY, Cunha Neto E, Coelho VP, Santos KS, Marin MLC, Kalil Filho JE, Mitne Neto M, Maciel RM de B, Passos-Bueno MR, Zatz M. MHC variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals [Internet]. Frontiers in Immunology. 2021 ;12 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2021.742881
Vancouver
Castelli EC, Castro MV de, Naslavsky M, Scliar MO, Silva NSB, Andrade HS, Souza AS, Pereira RN, Castro CFB, Mendes Júnior CT, Meyer D, Nunes K, Matos LRB, Silva MVR da, Wang JYT, Esposito J, Cória VR, Bortolin RH, Hirata MH, Magawa JY, Cunha Neto E, Coelho VP, Santos KS, Marin MLC, Kalil Filho JE, Mitne Neto M, Maciel RM de B, Passos-Bueno MR, Zatz M. MHC variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals [Internet]. Frontiers in Immunology. 2021 ;12 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2021.742881
Artigo de periodico
Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases (2021)
Freitas, Renata Caroline Costa de ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Aikawa, Elena
Source: Biomolecules. Unidade: FCF
Subjects: BIOMARCADORES, PROTEÍNAS, LIPÍDEOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, v. 11, p. 1-21 art. 388, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11030388. Acesso em: 02 nov. 2024.
APA
Freitas, R. C. C. de, Hirata, R. D. C., Hirata, M. H., & Aikawa, E. (2021). Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, 11, 1-21 art. 388. doi:10.3390/biom11030388
NLM
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/biom11030388
Vancouver
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/biom11030388

USP Schools

ReP

Filtros

USP Schools

Authors

USP affiliated authors

Subjects

Funding Agencies

Non normalized affiliation